Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III study.

Kropff M, Vogel M, Bisping G, Schlag R, Weide R, Knauf W, Fiechtner H, Kojouharoff G, Kremers S, Berdel WE.

Ann Hematol. 2017 Nov;96(11):1857-1866. doi: 10.1007/s00277-017-3065-z. Epub 2017 Sep 14.

PMID:
28905189
2.

Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH).

Appelmann I, Kreher S, Parmentier S, Wolf HH, Bisping G, Kirschner M, Bergmann F, Schilling K, Brümmendorf TH, Petrides PE, Tiede A, Matzdorff A, Griesshammer M, Riess H, Koschmieder S.

Ann Hematol. 2016 Apr;95(5):707-18. doi: 10.1007/s00277-016-2621-2. Epub 2016 Feb 26. Review.

PMID:
26916570
3.

Cancer Screening in Patients with Idiopathic Venous Thromboembolism--a Position Paper of the German Society of Hematology and Oncology Working Group on Hemostasis.

Matzdorff A, Riess H, Bergmann F, Bisping G, Koschmieder S, Parmentier S, Petrides PE, Sosada M.

Oncol Res Treat. 2015;38(9):454-8. doi: 10.1159/000437451. Epub 2015 Aug 5. Review.

PMID:
26407062
4.

Laparoscopic splenectomy for medically refractory immune thrombocytopenia (ITP): a retrospective cohort study on longtime response predicting factors based on consensus criteria.

Rijcken E, Mees ST, Bisping G, Krueger K, Bruewer M, Senninger N, Mennigen R.

Int J Surg. 2014 Dec;12(12):1428-33. doi: 10.1016/j.ijsu.2014.10.012. Epub 2014 Oct 29.

5.

Combination of romiplostim and rituximab: effective therapy of severe immune thrombocytopenia.

Pohlen M, Sargin B, Zicholl S, Bisping G, Müller-Tidow C, Berdel WE, Mesters R, Koschmieder S.

Eur J Haematol. 2010 Apr;84(4):362-4. doi: 10.1111/j.1600-0609.2009.01406.x. Epub 2009 Dec 24. No abstract available.

PMID:
20050881
6.

Minireview: Malassezia infections in immunocompromised patients.

Tragiannidis A, Bisping G, Koehler G, Groll AH.

Mycoses. 2010 May;53(3):187-95. doi: 10.1111/j.1439-0507.2009.01814.x. Epub 2009 Dec 17. Review.

PMID:
20028460
7.

An open-label dose-escalation study of BIBF 1120 in patients with relapsed or refractory multiple myeloma.

Kropff M, Kienast J, Bisping G, Berdel WE, Gaschler-Markefski B, Stopfer P, Stefanic M, Munzert G.

Anticancer Res. 2009 Oct;29(10):4233-8.

8.

Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer.

Landmeier S, Altvater B, Pscherer S, Juergens H, Varnholt L, Hansmeier A, Bollard CM, Moosmann A, Bisping G, Rossig C.

J Immunother. 2009 Apr;32(3):310-21. doi: 10.1097/CJI.0b013e31819b7c30.

9.

Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myeloma.

Bisping G, Wenning D, Kropff M, Gustavus D, Müller-Tidow C, Stelljes M, Munzert G, Hilberg F, Roth GJ, Stefanic M, Volpert S, Mesters RM, Berdel WE, Kienast J.

Clin Cancer Res. 2009 Jan 15;15(2):520-31. doi: 10.1158/1078-0432.CCR-08-1612.

10.

Intestinal graft-versus-host-disease staging by video capsule endoscopy.

Meister T, Heinzow H, Bisping G, Stelljes M, Schulte B, Berdel WE, Kienast J, Domschke W, Ullerich H.

Endoscopy. 2008 Sep;40 Suppl 2:E144. doi: 10.1055/s-2007-995767. Epub 2008 Jul 16. No abstract available.

PMID:
18633870
11.

Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells.

Reinmuth N, Rensinghoff S, Raedel M, Fehrmann N, Schwöppe C, Kessler T, Bisping G, Hilberg F, Roth GJ, Berdel W, Thomas M, Mesters RM.

Int J Oncol. 2007 Sep;31(3):621-6.

PMID:
17671690
12.

Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma.

Kropff M, Bisping G, Schuck E, Liebisch P, Lang N, Hentrich M, Dechow T, Kröger N, Salwender H, Metzner B, Sezer O, Engelhardt M, Wolf HH, Einsele H, Volpert S, Heinecke A, Berdel WE, Kienast J; Deutsche Studiengruppe Multiples Myelom,.

Br J Haematol. 2007 Aug;138(3):330-7.

PMID:
17614819
13.

Differential requirement for a cellular type-1 immune response in tumor-associated versus alloantigen-targeted GvT effects.

Stelljes M, Specht C, Albring J, Volkmann S, Schlösser V, Pauels HG, Poremba C, Bisping G, Opitz C, Scheffold C, Silling G, Kiehl M, Berdel WE, Kienast J.

Transplantation. 2007 Feb 15;83(3):314-22.

PMID:
17297406
14.

Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors.

Kulimova E, Oelmann E, Bisping G, Kienast J, Mesters RM, Schwäble J, Hilberg F, Roth GJ, Munzert G, Stefanic M, Steffen B, Brandts C, Müller-Tidow C, Kolkmeyer A, Büchner T, Serve H, Berdel WE.

Mol Cancer Ther. 2006 Dec;5(12):3105-12.

15.

Proteasome inhibition in multiple myeloma.

Kropff M, Bisping G, Wenning D, Berdel WE, Kienast J.

Eur J Cancer. 2006 Jul;42(11):1623-39. Epub 2006 Jul 3. Review.

PMID:
16820291
16.

Immunotherapy of B-cell malignancies with genetically engineered human CD8+ natural killer T cells.

Pieper M, Scheffold C, Duwe S, Rossig C, Bisping G, Stelljes M, Tedder TF, Jurgens H, Berdel WE, Kienast J.

Leukemia. 2006 Apr;20(4):729-32. No abstract available.

PMID:
16437143
17.

Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups.

Bisping G, Kropff M, Wenning D, Dreyer B, Bessonov S, Hilberg F, Roth GJ, Munzert G, Stefanic M, Stelljes M, Scheffold C, Müller-Tidow C, Liebisch P, Lang N, Tchinda J, Serve HL, Mesters RM, Berdel WE, Kienast J.

Blood. 2006 Mar 1;107(5):2079-89. Epub 2005 Nov 8.

PMID:
16278310
18.

Bortezomib in combination with dexamethasone for relapsed multiple myeloma.

Kropff MH, Bisping G, Wenning D, Volpert S, Tchinda J, Berdel WE, Kienast J.

Leuk Res. 2005 May;29(5):587-90. Epub 2005 Jan 15.

PMID:
15755512
19.

Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+ donor cell chimerism analysis.

Scheffold C, Kroeger M, Zuehlsdorf M, Tchinda J, Silling G, Bisping G, Stelljes M, Buechner T, Berdel WE, Kienast J.

Leukemia. 2004 Dec;18(12):2048-50. No abstract available.

PMID:
15470491
20.

Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets.

Stelljes M, Strothotte R, Pauels HG, Poremba C, Milse M, Specht C, Albring J, Bisping G, Scheffold C, Kammertoens T, Oelmann E, Silling G, Berdel WE, Kienast J.

Blood. 2004 Aug 15;104(4):1210-6. Epub 2004 Apr 15.

PMID:
15090450
21.

Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma.

Kropff MH, Lang N, Bisping G, Dominé N, Innig G, Hentrich M, Mitterer M, Südhoff T, Fenk R, Straka C, Heinecke A, Koch OM, Ostermann H, Berdel WE, Kienast J.

Br J Haematol. 2003 Aug;122(4):607-16.

PMID:
12899716
22.

Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma.

Bisping G, Leo R, Wenning D, Dankbar B, Padró T, Kropff M, Scheffold C, Kröger M, Mesters RM, Berdel WE, Kienast J.

Blood. 2003 Apr 1;101(7):2775-83. Epub 2002 Nov 27.

PMID:
12517814
23.

Differential diagnosis of "dysphagia" in an elderly woman.

Wedekind H, Bisping G, Attaie T, Wessling J, Tombach B, Breithardt G, Domschke W.

Clin Cardiol. 2002 Mar;25(3):132. No abstract available.

24.

Common bile duct obstruction due to candidiasis.

Domagk D, Bisping G, Poremba C, Fegeler W, Domschke W, Menzel J.

Scand J Gastroenterol. 2001 Apr;36(4):444-6.

PMID:
11336173
25.
26.

Anti-proliferative activity of protein kinase C in apical compartments of human colonic crypts: evidence for a less activated protein kinase C in small adenomas.

Assert R, Kötter R, Bisping G, Scheppach W, Stahlnecker E, Müller KM, Dusel G, Schatz H, Pfeiffer A.

Int J Cancer. 1999 Jan 5;80(1):47-53.

27.

[Red cell volume and jaundice in premature infants].

Bisping G, Dönges K, Dortmann A, Küster F, Reischauer HC.

Z Kinderheilkd. 1970;108(2):156-64. German. No abstract available.

PMID:
5534723

Supplemental Content

Loading ...
Support Center